Nov 10 (Reuters) - HHS:
HHS: FDA IS ALSO APPROVING TWO NEW DRUGS TO EXPAND TREATMENT OPTIONS FOR MENOPAUSAL SYMPTOMS
HHS: FDA NOT SEEKING TO REMOVE THE BOXED WARNING FOR ENDOMETRIAL CANCER FOR SYSTEMIC ESTROGEN-ALONE PRODUCTS
HHS: FDA, TO EXPAND TREATMENT OPTIONS FOR MENOPAUSAL SYMPTOMS, IS APPROVING A GENERIC VERSION OF PREMARIN (CONJUGATED ESTROGENS)